However, despite the large number of patients with gastric cancer worldwide, CSCs in gastric cancer have not been definitively reported, especially studies evaluating the correlation between the overexpression and clinical significance of CD133 in gastric cancer systematically. The gene discussed is PROM1; the disease is gastric cancer.